US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.15

+0.15500.67%

Volume:2K

Turnover:49.70K

Market Cap:4.63M

PE:- -

High:23.28

Open:23.00

Low:23.00

Close:23.00

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:84.31

T/O Rate:1.08%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Industrial Minerals Confirms Priority Gold Target at Laverton’s North Pool

Industrial Minerals Wins Strong Shareholder Backing for Galleon Metals Deal and Board Refresh

CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application

CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007

Protagenic Therapeutics Advances PT00114 Toward U.S. IND

Protagenic receives FDA pre-IND feedback supporting IND for PT00114

India's Central Bank Chief Says Its Net Short Dollar Position Is 'Very Manageable'

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Asia's Least Favored Stock Market Has Shifted, According to BofA Fund Manager Poll

Abbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211

Traders Report RBI Continues Selling Dollars to Bolster Rupee Exchange Rate

CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich

Simply Wall St.

Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans

Trump's Truth Social latest posts

Citi Expresses Optimism on Indian Equities, Adds Axis Bank to Top Picks List

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Market Participants Suggest RBI May Have Acted to Defense Rupee

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/IND/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.15,"timestamp":1787581445714,"preClose":22.995,"halted":0,"volume":2152,"delay":0,"changeRate":0.006740595781691567,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Trading","change":0.155,"latestTime":"08-24 10:30:46 EDT","open":23,"high":23.28,"low":23,"amount":49700.46152,"amplitude":0.012177,"askPrice":23.12,"askSize":100,"bidPrice":22.96,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":22.995,"sharesOutstanding":200001,"nav":23.031,"aum":4606217.85,"dividendRate":0.003395,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":23.1,"preClose":22.995,"latestTime":"09:29 EDT","volume":206,"amount":4758.869860000001,"timestamp":1787578199043,"change":0.105,"changeRate":0.004566,"amplitude":0.004784},"postHourTrading":{"tag":"盘后","latestPrice":22.885,"preClose":22.995,"latestTime":"16:10 EDT","volume":8,"amount":183.96,"timestamp":1787343004209,"change":-0.11,"changeRate":-0.004784,"amplitude":0},"volumeRatio":84.305597},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":84.305597,"shares":200001,"dividePrice":0.0786,"high":23.28,"amplitude":0.012177,"preClose":22.995,"low":23,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.15,"eps":0,"divideRate":0.003395,"volume":2152,"delay":0,"ttmEps":0,"open":23,"prevYearClose":24.78,"prevWeekClose":22.995,"prevMonthClose":22.885,"prevQuarterClose":22.88,"fiveDayClose":23.005,"twentyDayClose":22.495,"sixtyDayClose":22.475},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661048246","title":"Industrial Minerals Confirms Priority Gold Target at Laverton’s North Pool","url":"https://stock-news.laohu8.com/highlight/detail?id=2661048246","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661048246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 06:39","pubTimestamp":1787524775,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has issued an update. Industrial Minerals has reinterpreted existing aeromagnetic and gravity data over t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-confirms-priority-gold-target-at-lavertons-north-pool?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-confirms-priority-gold-target-at-lavertons-north-pool?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64QTZ34.USD","IND","MTX","BK4567","BK4585","BK4109","BK4559","POOL","BK4588","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661251858","title":"Industrial Minerals Wins Strong Shareholder Backing for Galleon Metals Deal and Board Refresh","url":"https://stock-news.laohu8.com/highlight/detail?id=2661251858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661251858?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:17","pubTimestamp":1787282249,"startTime":"0","endTime":"0","summary":"Industrial Minerals Limited ( ($AU:IND) ) has shared an announcement. Industrial Minerals Limited shareholders have overwhelmingly approved all res...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-wins-strong-shareholder-backing-for-galleon-metals-deal-and-board-refresh?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/industrial-minerals-wins-strong-shareholder-backing-for-galleon-metals-deal-and-board-refresh?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4109","MTX","BK4535","IND","PICK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163462206","title":"CSTONE PHARMA-B Gets NMPA Green Light for CS5007 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1163462206","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163462206?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:12","pubTimestamp":1787263936,"startTime":"0","endTime":"0","summary":"CSTONE PHARMA-B (02616) has announced that the Investigational New Drug (IND) application for CS5007, an EGFR/HER3 bispecific antibody-drug conjugate (ADC) and one of the core candidates in the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4080","BK4231","NETL","IND","BK1574","02616","BK1161","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661302932","title":"CStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS5007","url":"https://stock-news.laohu8.com/highlight/detail?id=2661302932","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661302932?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:07","pubTimestamp":1787263635,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals ( ($HK:2616) ) just unveiled an announcement. CStone Pharmaceuticals has secured rapid investigational new drug approval in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cstone-gains-rapid-china-ind-approval-for-egfr-her3-adc-cs5007?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","TBXU","NETL","IND","BK4080","ADC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661235479","title":"Protagenic Therapeutics Advances PT00114 Toward U.S. IND","url":"https://stock-news.laohu8.com/highlight/detail?id=2661235479","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661235479?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:04","pubTimestamp":1787241844,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics ( ($PTIX) ) has issued an announcement. On August 20, 2026, Protagenic Therapeutics announced that the U.S. Food and Drug A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/protagenic-therapeutics-advances-pt00114-toward-u-s-ind?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/protagenic-therapeutics-advances-pt00114-toward-u-s-ind?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","IND","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660735282","title":"Protagenic receives FDA pre-IND feedback supporting IND for PT00114","url":"https://stock-news.laohu8.com/highlight/detail?id=2660735282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660735282?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:50","pubTimestamp":1787230244,"startTime":"0","endTime":"0","summary":"Protagenic Therapeutics (PTIX) announced that it has received written responses from the U.S. Food and Drug Administration, FDA, to its Type B pre-...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagenic-receives-fda-pre-ind-feedback-supporting-ind-for-pt00114-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4139","BK4588","BK4585","PTIX","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122741128","title":"India's Central Bank Chief Says Its Net Short Dollar Position Is 'Very Manageable'","url":"https://stock-news.laohu8.com/highlight/detail?id=1122741128","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122741128?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:40","pubTimestamp":1787193618,"startTime":"0","endTime":"0","summary":"Reserve Bank of India Governor Sanjay Malhotra stated that the central bank's net forward short dollar position remains at a \"very manageable\" level, citing prior liquidity swap arrangements and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4523","INCO","SMIN","PIN","SCIN","EPI","TAJX","FLIBF","UUP","INDA","INDL","IND","NDIA","INQQ","NFTY","INDE","INDY","IOPP","UDN","GIND","IMVP","BK4585","BK4588","FLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660474641","title":"Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2660474641","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660474641?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:32","pubTimestamp":1787185920,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Aug.  20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, \"Telix\") today announces its financial results for the period ended June","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348062/0/en/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-stage-pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASX","BK4585","BK4139","LU0128526141.USD","SPRE","BK4526","TMS","IND","BK4141","BK4588","BK4121","TLX","SGDM","BK4543","BK4215","GDXJ","LU0757428866.USD","XME","LU1223082519.USD","LU1815336091.USD","CRL","SIL","IE00BFMHRM44.USD","LU1223083913.SGD","BK4530","LU1223082196.USD","MAA","CDE","LU0029874061.USD","BK4017","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129083876","title":"Asia's Least Favored Stock Market Has Shifted, According to BofA Fund Manager Poll","url":"https://stock-news.laohu8.com/highlight/detail?id=1129083876","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129083876?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:07","pubTimestamp":1787130439,"startTime":"0","endTime":"0","summary":"A recent survey conducted by Bank of America among fund managers reveals a notable shift in regional sentiment, with India now overtaking Indonesia as the most underweighted equity market in Asia....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKF","DFAE","QEMM","MEMX","PEMX","BK4550","INDA","TEMR","SPEM","BK4523","XCNY","EPI","INQQ","BKEM","RWEM","SCIN","XC","EMES","BK4588","MEM","MFEM","EEMV","VEU","SMIN","RAYE","EMXC","SCHE","BCHI","XSOE","DEXC","INDZ","INCO","INDQ","FLIN","SEEM","EEMA","ASIA","NDIA","FLIBF","NFTY","BBEM","FEMR","STXE","IND","IOPP","INDL","TEMX","INDE","TAJX","XCEM","AEF","EQLT","BK4585","GLIN","INDH","KEMX","IMVP","INDY","XXCH","VEXC","GIND","EET","AVEM","QLVE","PIN","HEEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660858414","title":"Abbisko Wins China IND Nod for Pan-KRAS Cancer Drug ABSK211","url":"https://stock-news.laohu8.com/highlight/detail?id=2660858414","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660858414?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:38","pubTimestamp":1787114321,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has provided an update. Abbisko Therapeutics has secured Investigational New Drug clearance from China’s Nati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-china-ind-nod-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-china-ind-nod-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189195744","title":"Traders Report RBI Continues Selling Dollars to Bolster Rupee Exchange Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=1189195744","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189195744?lang=en_us&edition=fundamental","pubTime":"2026-08-19 12:04","pubTimestamp":1787112277,"startTime":"0","endTime":"0","summary":"According to informed traders, the Indian central bank is actively selling US dollars in the domestic foreign exchange market to support the rupee's exchange rate. These traders requested anonymity...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIN","INDY","INDL","INQQ","EPI","NDIA","BK4585","BK4588","IMVP","UDN","NFTY","UUP","SCIN","SMIN","IND","INDE","GIND","IOPP","FLIBF","INDA","BK4523","TAJX","INCO","FLIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494978","title":"CARsgen Therapeutics Holdings (SEHK:2171) Gains On CT0596 IND Clearance, But Is The Valuation Too Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494978","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494978?lang=en_us&edition=fundamental","pubTime":"2026-08-19 02:24","pubTimestamp":1787077458,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has drawn fresh attention after its allogeneic CAR T-cell candidate CT0596 received IND clearance from China’s National Medical Products Administration for relapsed or refractory multiple myeloma.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe CT0596 IND clearance arrives as CARsgen Therapeutics Holdings trades at HK$14.7, with a 1 day share price return of 2.15% and a 90 day share price return down 16.62%. The 1 year total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-gains-on-ct0596-ind-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02171","BK1585","BK1161","BK4139","BK4539","LENZ","BK1587","BK4007","BK1574","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660949985","title":"Trump: University of Miami donates 1994 Ibogaine IND to accelerate treatment for veterans","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949985","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949985?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:57","pubTimestamp":1787072260,"startTime":"0","endTime":"0","summary":"President Donald Trump announced on August 18 that the University of Miami has donated its original 1994 Ibogaine Investigational New Drug (IND) application to the federal government, a move he said...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/40964","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","IND","IND.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180340970","title":"Citi Expresses Optimism on Indian Equities, Adds Axis Bank to Top Picks List","url":"https://stock-news.laohu8.com/highlight/detail?id=1180340970","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180340970?lang=en_us&edition=fundamental","pubTime":"2026-08-17 13:20","pubTimestamp":1786944032,"startTime":"0","endTime":"0","summary":"Citi has expressed a positive outlook on the Indian stock market, driven by better-than-expected first-quarter earnings and the Nifty 50 index trading near its long-term average valuation. Analysts...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","LU0128525689.USD","INDL","LU0130102774.USD","LU1267930227.SGD","FLIBF","LU0052756011.USD","BK4559","INQQ","BK4523","LU1244550577.SGD","LU1074936037.SGD","INDY","LU1366192091.USD","161121","LU0320765646.SGD","LU0098860793.USD","LU0314106906.USD","BK4534","LU1201861249.SGD","IND","NFTY","LU1506573853.SGD","LU0106831901.USD","PIN","LU2236285917.USD","LU2456880835.USD","LU0477156953.USD","LU1668664300.SGD","EPI","LU1244550494.USD","BK4588","LU0162691827.USD","LU1244550221.USD","LU2125154935.USD","LU0203345920.USD","LU0310800965.SGD","LU2125154778.USD","LU2417539215.USD","FTXO","GLIN","LU0980610538.SGD","LU1791807156.HKD","FLIN","SMIN","C","INDE","IE00BSNM7G36.USD","INCO","LU0203347892.USD","MNDmain","LU1162221912.USD","BK4585","IYF","BK4566","LU2462157665.USD","BK4504","LU2360032135.SGD","LU0072461881.USD","LU0170899867.USD","TFNS","BK4207","SCIN","NDIA","LU0130517989.USD","INDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126775","title":"Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126775?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:05","pubTimestamp":1786737900,"startTime":"0","endTime":"0","summary":"EB-003 Development Highlights:--  Continued advancing IND-enabling studies supporting the planned. submission of an Investigational New Drug  application for EB-003. --  Reported preclinical data demonstrating that EB-003 consistently. exhibited a non-hallucinogenic profile in a highly sensitive. --  Announced promising results from preclinical in vitro experiments. indicating no photoreactive potential for EB-003, further derisking its. continued development as a potential treatment of neuropsychiatric. --  Initiated genotoxicity studies to evaluate the potential for EB-003 to. interact with DNA and cause genetic mutations, a critical measure of. --  Secured U.S. Patent No. 12,605,361 pertaining to the Company's EVM301. Series of molecules being developed as potential treatments for mental","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4604","BK4585","03160","BK4555","TM","MEDX","BK4099","IND","HYLG","ENVB","IDNA","BK4588","BK4007","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659142000","title":"Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings","url":"https://stock-news.laohu8.com/highlight/detail?id=2659142000","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659142000?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:33","pubTimestamp":1786714380,"startTime":"0","endTime":"0","summary":"Combined company to trade on Nasdaq and operate as Fibrx Therapeutics, a fibrosis-focused company led by the Redx management team and boardCompany’s lead program will be RXC008, Redx’s GI-restricted p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345392/0/en/skye-bioscience-and-redx-pharma-announce-transaction-agreement-and-125-million-in-financings.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659914159","title":"Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659914159","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659914159?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:32","pubTimestamp":1786710720,"startTime":"0","endTime":"0","summary":"Exploratory analyses of patients with very severe social anxiety disorder demonstrated nominally statistically significant improvement in recently reported clinical studies FDA engagement planned duri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345334/0/en/vistagen-reports-fiscal-year-2027-first-quarter-financial-results-and-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616146","title":"Press Release: TuHURA Biosciences Reports Second Quarter 2026 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:45","pubTimestamp":1786707900,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Aug. 14, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc.  , a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's second quarter ended June 30, 2026, and provided a corporate update.\"We have made significant progress in advancing all our programs forward and are positioned to continue driving towards several anticipated milestones targeted for the second half of the year,\" said Dr. James Bianco, President and CEO of TuHURA Biosciences. \"In the second half, we anticipate receiving safe-to-proceed feedback from FDA and to initiating our Phase 1b/2 trial of VISTA in mutNPM1 r/r AML, initiating our in vivo POC studies for MDSC Inhibitors , potentially receiving orphan drug designation in Merkel cell carcinoma  for IFx-2.0, and potentially receiving orphan drug designation in AML for TBS-2025. The recent $50 million term credit facility made available to us by our largest ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4139","BK4232","R","HURA","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","KBWB","LCIZ","LU2264538146.SGD","LU1244550221.USD","LU2357305700.SGD","LU0390134368.USD","LU1548497426.USD","LU0912757837.SGD","LU0006306889.USD","IND","BK4596","LU1244550494.USD","TM","LCDL","LU0234570918.USD","03160","LCID","LU2089283258.USD","REZ","BK4551","LU0098860793.USD","LU1791710400.SGD","BK4581","LU0210528500.USD","LU1732800096.USD","LU2023251221.USD","BK4516","BK4585","LU2133065610.SGD","LU0314104364.USD","LU1989772923.USD","IAI","LU0158827948.USD","LU1732799900.SGD","LU0053666078.USD","LABU","BK4127","LU1244550577.SGD","LU2111349929.HKD","BK4099","LU0106261372.USD","LU1791710582.SGD","LU0795875169.SGD","LU1988902786.USD","LU0267386448.USD","VMRK","QNTM","LU0106831901.USD","IE00B775SV38.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155674567","title":"Market Participants Suggest RBI May Have Acted to Defense Rupee","url":"https://stock-news.laohu8.com/highlight/detail?id=1155674567","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155674567?lang=en_us&edition=fundamental","pubTime":"2026-08-14 12:50","pubTimestamp":1786683057,"startTime":"0","endTime":"0","summary":"Traders report that the Reserve Bank of India likely stepped into the foreign exchange market on Friday. The move is seen as a response to elevated oil prices and low risk appetite, driven by the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4523","FLIBF","FLIN","GIND","TAJX","IMVP","BK4585","INCO","NFTY","INDL","INDY","EPI","INDE","SMIN","INQQ","SCIN","BK4588","NDIA","IOPP","PIN","INDA","IND"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}